Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04069741 · ClinicalTrials.gov registry record · NA
Treating Depression in Patients With De Quervain's Tenosynovitis; An Integrated Web Based Skills Intervention
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT04069741: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT04069741 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04069741, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study evaluates a Decision Aid to help patients with de Quervain's tenosynovitis decide how to treat their condition. For patients with symptoms of depression, half the participants will receive a psychological intervention (Toolkit) to improve depression and pain from de Quervain's tenosynovitis. The investigators hypothesize that both the Decision Aid and the Toolkit will be feasible, and that the Toolkit will improve pain and function compared to usual care.
Interventions
- OTHER Decision Aid
- BEHAVIORAL Toolkit for de Quervain's
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2018-12-10 |
| Est. Completion | 2022-02-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04069741
The ClinicalTrials.gov registry entry for NCT04069741 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Decision Aid is the first listed.
NCT04069741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04069741 about?
NCT04069741 is a clinical study titled "Treating Depression in Patients With De Quervain's Tenosynovitis; An Integrated Web Based Skills Intervention". This study evaluates a Decision Aid to help patients with de Quervain's tenosynovitis decide how to treat their condition. For patients with symptoms of depression, half the participants will receive a psychological intervention (Toolkit) to improve depression and pain from de Quervain's tenosynovi...
What is the current status of trial NCT04069741?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2018-12-10. Estimated completion is 2022-02-19.
What interventions are being tested in trial NCT04069741?
The interventions under investigation include: Decision Aid (OTHER), Toolkit for de Quervain's (BEHAVIORAL).
Who is sponsoring clinical trial NCT04069741?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.